1001020-14-9 Usage
General Description
1H-Pyrazole-4-carboxaldehyde, 3-(trifluoromethyl)- is a chemical compound with the molecular formula C6H4F3N3O. It is an aldehyde derivative of pyrazole, a five-membered aromatic heterocyclic compound. The presence of a trifluoromethyl group at the 3-position of the pyrazole ring makes it a valuable building block in organic synthesis, particularly in the pharmaceutical industry. 1H-Pyrazole-4-carboxaldehyde, 3-(trifluoromethyl)- is known for its potential use as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. It also exhibits interesting properties that make it a promising candidate for further research and development in medicinal chemistry and material science.
Check Digit Verification of cas no
The CAS Registry Mumber 1001020-14-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,1,0,2 and 0 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1001020-14:
(9*1)+(8*0)+(7*0)+(6*1)+(5*0)+(4*2)+(3*0)+(2*1)+(1*4)=29
29 % 10 = 9
So 1001020-14-9 is a valid CAS Registry Number.
1001020-14-9Relevant articles and documents
SUBSTITUTED BICYCLE HETEROCYCLIC DERIVATIVES USEFUL AS ROMK CHANNEL INHIBITORS
-
Page/Page column 105; 106; 174, (2018/06/06)
Disclosed are compounds of Formula (I) or a salt thereof, wherein R1 is (II) or (III); each W is independently NR1b or O; Z is a bond or CHR1d; and R1, R2, Rd, R3, L1, L2, R1a, R1b, R1c, and n are define herein. Also disclosed are methods of using such compounds as inhibitors of ROMK, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating cardiovascular diseases.
PYRAZOLEALKANAMIDE SUBSTITUTED THIOPHENES AS AMPA POTENTIATORS
-
Page/Page column 53, (2008/06/13)
The present invention relates to a heterocyclic derivative according to Formula (I) wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceuti
